| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/23/1991 | US5034520 Glycoamininoglycans produced by depolymerization of heparin |
| 07/23/1991 | US5034519 Oligosaccharides, immunogens and vaccines, and methods for preparing such oligosaccharides, immunogens and vaccines |
| 07/23/1991 | US5034518 2-fluoro-9-(2-deoxy-2-fluoro-β-D-arabinofuranosyl) adenine nucleosides |
| 07/23/1991 | US5034517 Process for producing 2,6-dideoxy-2-fluoro-L-talopyranose |
| 07/23/1991 | US5034506 Uncharged morpholino-based polymers having achiral intersubunit linkages |
| 07/23/1991 | US5034420 Compositions and method for stabilization of anthralin comprising the addition of an oil soluble antioxidant and an anionic surfactant |
| 07/23/1991 | US5034419 N-cycloalkylalkylamines, process for their preparation, their use as medicament and their synthesis intermediates |
| 07/23/1991 | US5034418 Diphenylethylene derivatives, pharmaceutical compositions containing same and treatment methods |
| 07/23/1991 | US5034417 New alkanesulfonanilide derivatives, processes for preparation thereof and pharmaceutical composition comprising the same |
| 07/23/1991 | US5034416 Carboxylic acid compositions |
| 07/23/1991 | US5034415 Administering 5,8,11,14,17-eicosapentaenoic acid and omega-3-docosahexaenoic acid |
| 07/23/1991 | US5034414 Liquid emulsion for transfusion |
| 07/23/1991 | US5034413 Intraocular pressure reducing 9,11-diacyl prostaglandins |
| 07/23/1991 | US5034412 Method of inhibiting interleukin-1 release |
| 07/23/1991 | US5034411 Cardiovascular disorders or antiarrhythmia agents |
| 07/23/1991 | US5034406 Method for reducing or maintaining intraocular pressure |
| 07/23/1991 | US5034402 Methods and pharmaceutical compositions using pyrrolidine derivatives |
| 07/23/1991 | US5034401 Derivatives of (1-hydroxy-2-piperidylalkyl-indol-2-ones, 2-quinolinones, 2-benzo(B)azapinones, benzimidazol-2-ones, and quinazolin-2-ones, their preparation and their application in therapeutics |
| 07/23/1991 | US5034400 Method for preventing neurotoxic side effects of NMDA antagonists |
| 07/23/1991 | US5034399 Substituted 1,8-naphthyridines and their use in medicaments |
| 07/23/1991 | US5034398 1H-indazole-3-carboxamide-N-2-azabicyclo[2.2.2]octanes useful for treating anxiety, psychosis, neuralgia, migraine and cluster headaches |
| 07/23/1991 | US5034397 Stable, water soluble salt compositions of M-AMSA in 1-methyl-2-pyrrolidinone |
| 07/23/1991 | US5034396 Method of treating depression with optically active isomers of 20,21-dinoreburnamenines |
| 07/23/1991 | US5034395 Hypotensive agents, carboxylated dihydropyridines |
| 07/23/1991 | US5034394 Treatment of aids-HIV or HBV infections |
| 07/23/1991 | US5034392 4-(3-(4-oxothiazolidinyl)butynylamines |
| 07/23/1991 | US5034391 Piperazinylalkyl-3(2H)-pyridazinones and the use thereof as agents lowering blood pressure |
| 07/23/1991 | US5034390 Psychological disorders, antidepressants or treatment of anxiety |
| 07/23/1991 | US5034389 Riboflavin and a bulking agent of yeast, mold or bacteria formed by mixing and drying |
| 07/23/1991 | US5034387 2,4-triaminopyrimidine-3-oxides used in cosmetic and pharmaceutical compositions |
| 07/23/1991 | US5034386 Fungicides |
| 07/23/1991 | US5034385 2-(heteroarylsubstituted)phenyl carbapenem antibacterial agents |
| 07/23/1991 | US5034383 Hypotensive agents for bone disorders |
| 07/23/1991 | US5034382 Wound healing agents |
| 07/23/1991 | US5034381 2-(substituted amino) adenosines as antihypertensives |
| 07/23/1991 | US5034380 Anticarcinogenic agents against leukemia or tumors |
| 07/23/1991 | US5034379 Pharmaceutical formulation containing azapropazone |
| 07/23/1991 | US5034230 Anti-allergic ophthalmics |
| 07/23/1991 | US5034228 Skin cream with carrier, lipids or liposomes and retinoids |
| 07/23/1991 | US5034224 Method and composition for treating protozoal infections |
| 07/23/1991 | CA2074097A1 Drugs and use thereof |
| 07/23/1991 | CA2034673A1 1-phenylalkyl-3-phenylurea derivative |
| 07/23/1991 | CA2034616A1 Thiazolidine derivatives having anti-hypertensive activity and their therapeutic use |
| 07/23/1991 | CA2034596A1 Benzoquinone antiallergy and antiinflammatory agents |
| 07/23/1991 | CA2034516A1 Transdermal administration of zwitterionic drugs |
| 07/23/1991 | CA2034171A1 Method of treating erectile dysfunction |
| 07/23/1991 | CA2032817A1 Monobactam hydrazides containing catechol sulfonic acid groups |
| 07/23/1991 | CA1286844C Pharmaceutical compositions |
| 07/23/1991 | CA1286693C Cholecalciferol derivatives |
| 07/23/1991 | CA1286683C Hmg-coa reductase inhibitors |
| 07/23/1991 | CA1286681C Substituted 2-aminotetralins |
| 07/23/1991 | CA1286679C 7-oxabicycloheptane substituted diacid diamide prostaglandin analogs |
| 07/23/1991 | CA1286675C Adrenergic compounds |
| 07/23/1991 | CA1286673C 1-phenoxy-propyl-4-¬n(phenyl)-thiocarbamoyl or carbamoyl|- trans-decahydroquinoline compounds |
| 07/23/1991 | CA1286671C Trans-6- 2-heteroaryl-3,5-disubstituted)pyrazol-4-yl)- ethyl) - or ethenyl) tetrahydro-4-hydroxypyran- 2-one inhibitors of cholesterol biosynthesis |
| 07/23/1991 | CA1286670C Triazine salt |
| 07/23/1991 | CA1286669C Aminoalkylphenoxy derivatives |
| 07/23/1991 | CA1286668C Imidazo[1,2-a]quinoline derivatives, their preparation and their application in therapy |
| 07/23/1991 | CA1286667C 4-(2-pyrimidinyl)-1-piperazinyl heterocyclic carbonyl derivatives |
| 07/23/1991 | CA1286666C Substituted 8-phenylxanthines |
| 07/23/1991 | CA1286665C Pyrido [1,2-a] pyrimidine derivatives |
| 07/23/1991 | CA1286663C 1-substituted oxindole-3-carboxamides as antiinflammatory and analgesic agents |
| 07/23/1991 | CA1286661C 2,6-disubstituted penem compounds |
| 07/23/1991 | CA1286608C Continuous release phenylethanolamine derivative compositions |
| 07/20/1991 | WO1991010669A1 Chelating compounds |
| 07/20/1991 | WO1991010659A1 Oxathiane derivatives |
| 07/20/1991 | WO1991010657A1 New thiazole derivatives |
| 07/20/1991 | WO1991010656A1 Thiazole derivatives |
| 07/20/1991 | WO1991010418A1 Dermatologic preparation |
| 07/20/1991 | CA2074180A1 Thiazole derivatives |
| 07/20/1991 | CA2074175A1 Thiazole derivatives |
| 07/20/1991 | CA2074173A1 Oxathiane derivatives |
| 07/20/1991 | CA2072080A1 Chelating compounds |
| 07/20/1991 | CA2049071A1 Dermatological external agent |
| 07/20/1991 | CA2034576A1 Further therapeutic uses of cyanocobalamin |
| 07/20/1991 | CA2034524A1 Di- and tripeptide renin inhibitors containing non-peptidal conformationally-constrained tripeptide mimic for leu10-val11-ile12 |
| 07/20/1991 | CA2034520A1 Pharmaceutical composition for protecting the gastroduodenal mucosa |
| 07/20/1991 | CA2033680A1 Administration method of antithrombin |
| 07/19/1991 | CA2034315A1 Orally active renin inhibitors |
| 07/19/1991 | CA2034242A1 Macrocyclic tetraaza compounds containing a six-membered ring, processes for their production, and pharmaceutical agents containing same |
| 07/18/1991 | DE4001323A1 2,13-disubstituierte ergoline, deren herstellung und verwendung in arzneimitteln 2,13-disubstituted ergoline, their production and use in medicinal products |
| 07/18/1991 | DE4001146A1 Use of phenobarbital and phetharbital to treat liver diseases - by lowering physiologically raised bile acid levels, with analysis of bile acid metabolites in urine to monitor treatment |
| 07/18/1991 | DE4001060A1 Use of octa:deca:di:enoic derivs. - as aromatase inhibitors in treatment of prostate tumours, prostate hyperplasia or mammary carcinoma |
| 07/18/1991 | DE4001002A1 N'N'-di:(nitroxyalkyl) pyridine-2,4- and -2,5-di:carboxamide derivs. - used as proline and lysine hydroxylase inhibitors for use a immuno:suppressive, fibro-suppressive and collagen biosynthesis inhibitors |
| 07/18/1991 | CA2034246A1 Atropine-salbutamol aerosol |
| 07/18/1991 | CA2034189A1 Indole-substituted five-membered heteroaromatic compounds |
| 07/17/1991 | WO1991010655A1 1,4,10,13-tetraoxa-7,16-diazacyclooctadecane derivatives, pharmaceutical compositions containing them and their use for the removal of toxic metal ions and radioactive isotopes from the living organism |
| 07/17/1991 | EP0437415A2 Crystalline form of the hydrochloride of 4-(5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-5-yl)-benzonitrile |
| 07/17/1991 | EP0437406A1 Pharmaceutical composition in stable aqueous suspension form containing sucralfate and anti-acidic substance as well as process for preparing it |
| 07/17/1991 | EP0437382A1 Thimidin derivatives, their preparation and compositions containing them |
| 07/17/1991 | EP0437368A1 Fluid ophthalmic composition based on lipid microparticles containing at least one active principle |
| 07/17/1991 | EP0437346A1 Anti-viral fraction of aqueous Lentinus edodes extract |
| 07/17/1991 | EP0437294A1 Oral pharmaceutical compositions in unit dosage form |
| 07/17/1991 | EP0437244A1 Glidobactin PF-1 peptide antitumor antibiotics |
| 07/17/1991 | EP0437225A1 Topical preparations |
| 07/17/1991 | EP0437128A2 Use of derivatives of fluoroquinolone in the treatment of pneumocystis carinii pneumonia |
| 07/17/1991 | EP0437120A1 Pyridone derivatives, process for their preparation, novel obtained intermediates, their use as medicines and pharmaceutical compositions containing them |
| 07/17/1991 | EP0437103A2 Substituted 5-(alkyl)carboxamide imidazoles |
| 07/17/1991 | EP0437083A1 Analgesic and anti-inflammatory medicine |
| 07/17/1991 | EP0437058A1 Formation of hydroxyaromatic ketoacetal from an hydroxyaromatic methylketone and production of 5-(4'-hydroxyphenyl)hydantoin and D-p-hydroxyphenylglycine from 4-hydroxyacetophenone |